Advisor to the Minister for Artificial Intelligence (AI) – Ministry of Communications & Information Technology (MCIT)
Golestan Abbas Kamel Radwan is the Advisor to the Minister for Artificial Intelligence (AI) at the Ministry of Communications and Information Technology (MCIT).
Radwan possesses over 17 years of experience in technology areas, with international experience in AI, cloud computing, engineering management, strategic planning and product management.
Prior to her appointment at MCIT, Radwan held several executive positions. She served as Director of AI Products Unit at London-based health tech startup Babylon Health, where she led the AI product portfolio, leading a team of doctors, engineers, and AI scientists and designers to create an intelligent mobile platform for medical diagnosis, predictive health and chronic disease management.
Before Babylon, Radwan spent over 10 years in the technology industry in Germany, UK and US, where she held various positions in engineering management, strategic planning and product management. She was the Vice President of Product Strategy at OnApp-UK for cloud management systems, and the Cloud Product Marketing Manager for UK-based Canonical/Ubuntu. She also worked as the UK Marketing Manager at Japanese software company NTT Data, and the Solutions Marketing Manager and Leadership Program participant at Avaya Inc. in the UK and US. She also spent several years as a Software Engineer and Team Leader at Novell Inc in Germany.
As an AI expert, Radwan participated as a speaker at several AI conferences in Europe and the US, and served as a consultant to many startups and investors in AI areas, especially health systems.
Radwan earned a BSc in Computer Engineering from Cairo University in 2000. She received her MBA from London Business School (LBS), UK, in 2006, and a MSc in Clinical Engineering and Healthcare Technology Management from City University of London, UK, in 2012. She is pursuing her PhD thesis in computer engineering, specializing in AI and bioinformatics analysis from the Royal Holloway, University of London, UK.